In this episode, Akshat outlines the salient features of CAR or TCR-engineered T cells, and deigns to ponder: is one modality just objectively better than the other?

Check out our memes on Facebook (@antibuddies), Twitter (@antibuddiesP), and Instagram (@AntibuddiesPodcast).

YouTube channel: https://www.youtube.com/channel/UCxyrHotyyY3sSwcp1zigeCw

Send us your queries/questions/suggestions at antibuddies1@gmail.com.

Website: Antibuddies – Science Communication & Immunology (Antibuddies.org)